Champlain Investment Partners LLC Increases Stock Holdings in STERIS plc (NYSE:STE)

Champlain Investment Partners LLC lifted its position in STERIS plc (NYSE:STE - Free Report) by 4.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 547,448 shares of the medical equipment provider's stock after acquiring an additional 23,825 shares during the period. Champlain Investment Partners LLC owned 0.56% of STERIS worth $112,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in STE. Avalon Trust Co acquired a new stake in shares of STERIS during the fourth quarter worth about $30,000. Human Investing LLC acquired a new stake in shares of STERIS in the fourth quarter worth $31,000. Anfield Capital Management LLC raised its holdings in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares during the last quarter. Central Pacific Bank Trust Division lifted its position in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its holdings in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Upgrades and Downgrades

STE has been the subject of several analyst reports. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Monday, April 7th. JMP Securities restated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Stephens reissued an "overweight" rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, STERIS presently has an average rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Price Performance

Shares of STERIS stock traded up $3.82 during mid-day trading on Tuesday, reaching $222.60. 60,510 shares of the stock traded hands, compared to its average volume of 525,056. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The business has a 50-day moving average of $222.48 and a 200 day moving average of $218.90. The stock has a market capitalization of $21.87 billion, a PE ratio of 47.26 and a beta of 0.87. STERIS plc has a fifty-two week low of $198.13 and a fifty-two week high of $248.24.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's dividend payout ratio is currently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.